A carregar...
Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematoma
INTRODUCTION: Idarucizumab is the first effective humanized monoclonal antibody fragment developed specifically as a reversal agent for dabigatran, a Direct Oral Anticoagulant. Despite recent trials demonstrating reversal of clinically relevant bleeding, there is a paucity of data on use outside the...
Na minha lista:
| Publicado no: | Trauma Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5887121/ https://ncbi.nlm.nih.gov/pubmed/29644298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcr.2017.12.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|